Aster DM Merger: 97% Shareholder & 100% Creditor Approval Secured

Introduction

Aster DM Healthcare Limited has cleared a critical milestone in its proposed amalgamation with Quality Care India Limited, securing overwhelming approval from both its shareholders and unsecured trade creditors. In separate meetings held on March 10, 2026, stakeholders voted decisively in favour of the scheme, moving the transaction closer to creating one of India's top three hospital chains. The approvals mark the final major step in the regulatory process before the final sanction from the National Company Law Tribunal (NCLT).

Overwhelming Stakeholder Endorsement

The NCLT-convened meetings, conducted via video conferencing, resulted in a strong mandate for the merger. Shareholders approved the resolution with 96.68% of the votes cast in favour. The support from unsecured trade creditors was even more emphatic, with the resolution receiving 100% approval from those who participated in the voting process. This unanimous creditor consent underscores the financial community's confidence in the strategic rationale of the amalgamation.

The NCLT-Mandated Process

The meetings were held following a directive from the Hyderabad Bench of the NCLT. The process was managed with transparency and accessibility for all stakeholders. A comprehensive voting window was provided, which included remote e-voting from March 6 to March 9, 2026, in addition to electronic voting during the meetings themselves. The proceedings were chaired by an appointed advocate, and the results were verified by Mr. Mohit Kumar Goyal, a Practicing Company Secretary, who served as the NCLT-appointed scrutiniser. The official results have been filed with the stock exchanges and made available on the company's website, adhering to regulatory disclosure requirements.

A New Healthcare Powerhouse

The merger is set to create a formidable entity in the Indian healthcare landscape. The combined network will establish a significant presence across the country, positioning it as one of the largest hospital chains by multiple metrics. Dr. Azad Moopen, Founder Chairman of Aster DM Healthcare, noted that the strong support reflects stakeholder confidence in the long-term value creation potential of the combined enterprise. The merger integrates Aster's patient-centric approach with Quality Care's institutional strength and growth expertise.

Strategic Rationale and Synergies

The primary driver for the amalgamation is the creation of a resilient and future-ready healthcare organization. The combined entity is expected to leverage significant operational synergies, with management projecting an EBITDA upside potential of 10-15%. Key areas for synergy include centralized procurement, the development of an integrated doctor model, and the optimization of corporate functions. This operational efficiency is aimed at improving patient access and clinical outcomes, particularly in underserved Tier 2 and Tier 3 cities where the combined network will have a stronger footprint.

Financial Structure of the Deal

The scheme of amalgamation outlines a clear share exchange ratio. Upon the merger becoming effective, shareholders of Quality Care India Limited will receive 977 equity shares of Aster DM Healthcare for every 1,000 shares they hold in QCIL. This structure was part of the initial agreement that had already received 99.998% approval from shareholders in a preceding share swap arrangement, indicating early and widespread support for the transaction's financial terms.

The Regulatory Journey

This recent stakeholder approval is the culmination of a lengthy regulatory process. The merger plan had previously secured essential clearances from other key bodies. The Competition Commission of India (CCI) gave its approval, and both the BSE and the National Stock Exchange (NSE) had issued 'No Objection' letters for the scheme. With these regulatory hurdles cleared, the NCLT-convened meetings represented the final major milestone before the tribunal issues its final order.

Governance and Next Steps

To ensure robust corporate governance, both Aster's promoters and Blackstone have agreed to specific measures, including waiving director nomination rights if their respective shareholdings fall below 10%. With shareholder and creditor approvals now in place, Aster DM Healthcare will file the results with the NCLT. The company anticipates completing the entire merger process within the next quarter, subject to receiving the final sanction from the NCLT and fulfilling any remaining procedural conditions. The successful completion will formally establish 'Aster DM Quality Care Ltd' as a new leader in the Indian healthcare industry.